Skip to content

ADMA Biologics ADMA Plasma Collection Centers — Sales & Marketing

Other segment segments

ADMA Bio Manufacturing
$7.2M+19.1%

Similar metrics at other companies

Haemonetics logo
HAEPlasma — SG&A
$27.27M+11.3%
Haemonetics logo
HAEPlasma — Cost of goods sold
$54.39M+14.9%
Haemonetics logo
HAEPlasma — R&D
$4.94M+15.4%
Haemonetics logo
HAEPlasma — Costs incurred, net of reversals
$0
Haemonetics logo
HAEPlasma — Total net revenues
$130.29M+2.8%
Haemonetics logo
HAEBlood Center — SG&A
$13.48M-9.6%

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.02B-54.5%

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's plasma collection centers — sales & marketing.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's plasma collection centers — sales & marketing?
ADMA Biologics (ADMA) reported plasma collection centers — sales & marketing of $0 in Q1 2026.
What does plasma collection centers — sales & marketing mean?
Includes costs incurred to attract plasma donors and promote the brand presence of collection centers within their local communities. This metric measures the efficiency of donor acquisition strategies and marketing outreach. High spending relative to revenue may indicate competitive pressure in the plasma collection market.